Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

  • Joseph M. Herman
  • , Daniel T. Chang
  • , Karyn A. Goodman
  • , Avani S. Dholakia
  • , Siva P. Raman
  • , Amy Hacker-Prietz
  • , Christine A. Iacobuzio-Donahue
  • , Mary E. Griffith
  • , Timothy M. Pawlik
  • , Jonathan S. Pai
  • , Eileen O'Reilly
  • , George A. Fisher
  • , Aaron T. Wild
  • , Lauren M. Rosati
  • , Lei Zheng
  • , Christopher L. Wolfgang
  • , Daniel A. Laheru
  • , Laurie A. Columbo
  • , Elizabeth A. Sugar
  • , Albert C. Koong

Research output: Contribution to journal › Article › peer-review

460 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science